Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1626
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18548784 | (S)-3-AMINO-4,4-DIHALOCYCLOPENT-1-ENECARBOXYLIC ACID AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE | Non-Final OA | Northwestern University |
| 18570515 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR | Non-Final OA | LG CHEM, LTD. |
| 18548747 | 4-AMINO-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | Non-Final OA | JANSSEN PHARMACEUTICA NV |
| 17709401 | USE OF DELTA-TOCOTRIENOL IN THE PREVENTION OF CANCER AND CANCER RECURRENCE | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18294459 | METHOD OF TREATING AND/OR PREVENTING TYPE 1 DIABETES WITH CEPHARANTHINE | Non-Final OA | ALBERT EINSTEIN COLLEGE OF MEDICINE |
| 17345256 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | Non-Final OA | Vertex Pharmaceuticals Incorporated |
| 17045083 | SOCE FACILITATORS FOR USE IN TREATING OR PREVENTING VIRAL INFECTIONS | Non-Final OA | THE UNIVERSITY OF NOTTINGHAM |
| 18574404 | METHODS FOR TREATING DEPRESSIVE STATES | Non-Final OA | BioXcel Therapeutics, Inc. |
| 18566306 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | Non-Final OA | NIHON NOHYAKU CO., LTD. |
| 18546616 | USE OF NEUROACTIVE STEROID FOR TREATMENT OF SEXUAL DYSFUNCTION | Non-Final OA | Sage Therapeutics, Inc. |
| 18281861 | INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1) AND USES THEREOF | Non-Final OA | YEDA RESEARCH AND DEVLOPMENT CO. LTD. |
| 18253846 | SALT FORM USED AS CDC7 INHIBITOR AND CRYSTAL FORM THEREOF | Non-Final OA | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| 18015856 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Non-Final OA | NOVARTIS PHARMA AG |
| 18266208 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | Non-Final OA | LT MATERIALS CO., LTD. |
| 17350321 | LYSINE-SPECIFIC HISTONE DEMETHYLASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS | Final Rejection | Imago Biosciences, Inc. |
| 17434029 | PROTEIN SECRETION INHIBITORS | Final Rejection | KEZAR LIFE SCIENCES |
| 18053332 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | Non-Final OA | Edgewise Therapeutics, Inc. |
| 17801293 | Lymphocyte Population and Methods for Producing Same | Non-Final OA | AVM Biotechnology, LLC |
| 17911302 | COMPOSITIONS, METHODS AND USES OF COMBINATION TREATMENTS FOR BLOOD CANCERS | Final Rejection | University of New Brunswick |
| 17272738 | USE OF DELTA-TOCOTRIENOL FOR TREATING CANCER | Final Rejection | H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy